Ciprobay

Ciprobay may be available in the countries listed below.

Ingredient matches for Ciprobay

Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Ciprobay in the following countries:

• Bosnia & Herzegowina


• Croatia (Hrvatska)


• Germany


• Hungary


• Malaysia


• Slovenia

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprobay in the following countries:

• Bahrain


• Bosnia & Herzegowina


• Croatia (Hrvatska)


• Czech Republic


• Egypt


• Georgia


• Germany


• Greece


• Hungary


• Iran


• Jordan


• Kuwait


• Lebanon


• Oman


• Philippines


• Poland


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• South Africa


• Sudan


• Thailand


• United Arab Emirates


• Vietnam

Ciprofloxacin lactate (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprobay in the following countries:

• Bulgaria


• China


• Croatia (Hrvatska)


• Czech Republic


• Hungary


• Philippines


• Romania


• Singapore


• Thailand

International Drug Name Search

Demadex

Demadex is a brand name of torsemide, approved by the FDA in the following formulation(s):

DEMADEX (torsemide - tablet; oral)

• 
  Manufacturer: MEDA PHARMS
  
  Approval date: August 23, 1993
  
  Strength(s): 100MG ^[AB], 10MG ^[AB], 20MG ^[RLD][AB], 5MG ^[AB]

Has a generic version of Demadex been approved?

Yes. The following products are equivalent to Demadex:

torsemide tablet; oral

• 
  Manufacturer: APOTEX INC
  
  Approval date: May 31, 2005
  
  Strength(s): 100MG ^[AB], 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA
  
  Approval date: October 17, 2007
  
  Strength(s): 100MG ^[AB], 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: HETERO DRUGS
  
  Approval date: January 27, 2009
  
  Strength(s): 100MG ^[AB], 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: PAR PHARM
  
  Approval date: May 27, 2003
  
  Strength(s): 100MG ^[AB], 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: PLIVA PHARM IND
  
  Approval date: May 30, 2003
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: PLIVA PHARM IND
  
  Approval date: October 19, 2004
  
  Strength(s): 100MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: March 1, 2005
  
  Strength(s): 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: SUN PHARM INDS
  
  Approval date: February 26, 2008
  
  Strength(s): 100MG ^[AB], 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: May 14, 2002
  
  Strength(s): 100MG ^[AB], 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: VINTAGE PHARMS
  
  Approval date: March 22, 2011
  
  Strength(s): 100MG ^[AB], 10MG ^[AB], 20MG ^[AB], 5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Demadex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Demadex.

See also...

• Demadex Consumer Information (Wolters Kluwer)
• Demadex Solution Consumer Information (Wolters Kluwer)
• Demadex Consumer Information (Cerner Multum)
• Demadex Advanced Consumer Information (Micromedex)
• Demadex Intravenous Advanced Consumer Information (Micromedex)
• Demadex AHFS DI Monographs (ASHP)
• Torsemide Consumer Information (Wolters Kluwer)
• Torsemide Solution Consumer Information (Wolters Kluwer)
• Torsemide Consumer Information (Cerner Multum)
• Torsemide Advanced Consumer Information (Micromedex)
• Torsemide Intravenous Advanced Consumer Information (Micromedex)
• Torsemide AHFS DI Monographs (ASHP)

Tédralan

Tédralan may be available in the countries listed below.

Ingredient matches for Tédralan

Theophylline

Theophylline is reported as an ingredient of Tédralan in the following countries:

• Monaco

International Drug Name Search

Mebendazol Agrand

Mebendazol Agrand may be available in the countries listed below.

Ingredient matches for Mebendazol Agrand

Mebendazole

Mebendazole is reported as an ingredient of Mebendazol Agrand in the following countries:

• Argentina

International Drug Name Search

Pamergan P100

Pamergan P100 may be available in the countries listed below.

Ingredient matches for Pamergan P100

Pethidine

Pethidine is reported as an ingredient of Pamergan P100 in the following countries:

• United Arab Emirates

Pethidine hydrochloride (a derivative of Pethidine) is reported as an ingredient of Pamergan P100 in the following countries:

• Bahrain


• Egypt


• Iran


• Iraq


• Jordan


• Kuwait


• Lebanon


• Oman


• Qatar


• Saudi Arabia


• Syria


• United Kingdom


• Yemen

Promethazine

Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Pamergan P100 in the following countries:

• Bahrain


• Egypt


• Iran


• Iraq


• Jordan


• Kuwait


• Lebanon


• Qatar


• Saudi Arabia


• Syria


• United Arab Emirates


• United Kingdom


• Yemen

Promethazine hydroxyethylchloride (a derivative of Promethazine) is reported as an ingredient of Pamergan P100 in the following countries:

• Oman

International Drug Name Search

Oralsone

Oralsone may be available in the countries listed below.

Ingredient matches for Oralsone

Hydrocortisone

Hydrocortisone 21-(hydrogen succinate) (a derivative of Hydrocortisone) is reported as an ingredient of Oralsone in the following countries:

• Argentina


• Spain

International Drug Name Search

Salbodil

Salbodil may be available in the countries listed below.

Ingredient matches for Salbodil

Salbutamol

Salbutamol is reported as an ingredient of Salbodil in the following countries:

• Peru

International Drug Name Search

Cefpirome

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DE02

CAS registry number (Chemical Abstracts Service)

0084957-29-9

Chemical Formula

C22-H22-N6-O5-S2

Molecular Weight

514

Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

1-(((6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-6,7-dihydro-5H-1-pyrindinium hydroxide, inner salt

Foreign Names

• Cefpiromum (Latin)
• Cefpirom (German)
• Cefpirome (French)
• Cefpiroma (Spanish)

Generic Names

• Cefpirome (OS: BAN, DCF)
• HR 810 (IS: HoechstMarion)
• Cefpirome Sulfate (OS: USAN)
• Cefpirome Sulphate (OS: BANM)
• Cefpirome Sulfate (PH: JP XV)

Brand Names

• Cefir
  Fahrenheit, Indonesia



• Cefnos
  Pharos, Indonesia



• Cefrin
  Dexa Medica, Indonesia



• Cefrom
  Sanofi-Aventis, Indonesia



• Cefron
  Aventis, Peru



• Ethirom
  Ethica Industri Farmasi, Indonesia



• Morcef
  Dexa Medica, Indonesia



• Romicef
  Meprofarm, Indonesia



• Sopirom
  Soho, Indonesia



• Bactirom
  Sanbe, Indonesia



• Broact
  Sanofi Aventis, Japan



• Cef-4
  Lupin, Myanmar



• Cefrom
  Aventis, Bulgaria; Aventis, India; Aventis, Luxembourg; Aventis, Peru; Aventis, Serbia; Patheon, Bulgaria; Sanofi-Aventis, Austria; Sanofi-Aventis, France; Sanofi-Aventis, Romania; Sanofi-Aventis, Thailand; Sanofi-Aventis, Taiwan; Sanofi-Aventis, South Africa



• Interome
  Interbat, Indonesia



• Keiten
  Chugai, Japan; Winthrop, Japan



• Lanpirome
  Landson, Indonesia



• Nufirom
  Guardian Pharmatama, Indonesia



• Xenoprom
  Novell, Indonesia



• Yarox
  Yarindo Farmatama, Indonesia

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.